240 related articles for article (PubMed ID: 6093054)
1. Reversion to neurovirulence of the live-attenuated Sabin type 3 oral poliovirus vaccine.
Cann AJ; Stanway G; Hughes PJ; Minor PD; Evans DM; Schild GC; Almond JW
Nucleic Acids Res; 1984 Oct; 12(20):7787-92. PubMed ID: 6093054
[TBL] [Abstract][Full Text] [Related]
2. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
Svitkin YV; Cammack N; Minor PD; Almond JW
Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b.
Stanway G; Hughes PJ; Mountford RC; Reeve P; Minor PD; Schild GC; Almond JW
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1539-43. PubMed ID: 6324200
[TBL] [Abstract][Full Text] [Related]
4. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine.
Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC
J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836
[TBL] [Abstract][Full Text] [Related]
5. Studies on the attenuation of the Sabin type 3 oral polio vaccine.
Almond JW; Westrop GD; Evans DM; Dunn G; Minor PD; Magrath D; Schild GC
J Virol Methods; 1987 Aug; 17(1-2):183-9. PubMed ID: 2822753
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
7. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome.
Evans DM; Dunn G; Minor PD; Schild GC; Cann AJ; Stanway G; Almond JW; Currey K; Maizel JV
Nature; 1985 Apr 11-17; 314(6011):548-50. PubMed ID: 2986004
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
9. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
10. The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1.
Stanway G; Cann AJ; Hauptmann R; Hughes P; Clarke LD; Mountford RC; Minor PD; Schild GC; Almond JW
Nucleic Acids Res; 1983 Aug; 11(16):5629-43. PubMed ID: 6310508
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.
Weeks-Levy C; Tatem JM; DiMichele SJ; Waterfield W; Georgiu AF; Mento SJ
Virology; 1991 Dec; 185(2):934-7. PubMed ID: 1660210
[TBL] [Abstract][Full Text] [Related]
12. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain).
Ubertini TR; Cioni C; Perini L; Gagnoni S
Vaccine; 1988 Dec; 6(6):481-2. PubMed ID: 2854337
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
Rezapkin GV; Douthitt M; Dragunsky E; Chumakov KM
Virus Res; 1999 Dec; 65(2):111-9. PubMed ID: 10581384
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
15. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees.
Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J
Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence from neurovirulent and attenuated strains of type 3 poliovirus.
Almond JW; Cann AJ; Minor PD; Reeve P; Schild GC; Hauptmann R; Stanway G
Rev Infect Dis; 1984; 6 Suppl 2():S487-93. PubMed ID: 6330844
[TBL] [Abstract][Full Text] [Related]
17. Point mutations involved in the attenuation/neurovirulence alternation in type 1 and 2 oral polio vaccine strains detected by site-specific polymerase chain reaction.
Guillot S; Otelea D; Delpeyroux F; Crainic R
Vaccine; 1994 May; 12(6):503-7. PubMed ID: 8036823
[TBL] [Abstract][Full Text] [Related]
18. Genomic modifications in naturally occurring neurovirulent revertants of Sabin 1 polioviruses.
Otelea D; Guillot S; Furione M; Combiescu AA; Balanant J; Candrea A; Crainic R
Dev Biol Stand; 1993; 78():33-8. PubMed ID: 8099049
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid sequence of the region of the genome encoding capsid protein VP1 of neurovirulent and attenuated type 3 polioviruses.
Stanway G; Cann AJ; Hauptmann R; Mountford RC; Clarke LD; Reeve P; Minor PD; Schild GC; Almond JW
Eur J Biochem; 1983 Oct; 135(3):529-33. PubMed ID: 6311539
[TBL] [Abstract][Full Text] [Related]
20. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.
Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]